CAR-T specialist Caribou culls pipeline and seeks exit deal
Despite Nobel Prize origins, Caribou has succumbed to a sector shifting its focus to in vivo CAR-T approaches.
Cytiva Navigating cell therapy WP 4
FDA approves first gene therapy for Sanfilippo syndrome type A
Cellares and GenomeFrontier to assess automated GF-CART01 production
Encoded secures $275m for Dravet syndrome gene therapy
Typewriter raises $56m Series A to progress non-viral gene therapy platform
FDA places clinical hold on Regenxbio’s RGX-121 in MPS II trial
A strategic shift for gene therapies: manufacturing and market size take centre stage
FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy
